tested in children , said Ganley , the director of the FDA 's office of nonprescription drug products .
weeks after safety reviewers within the Food and Drug Administration urged to consider an outright ban for children under 6 .
`` The reason the makers of over-the-counter medicine for infants are withdrawing these medicines is that there have been rare patterns of misuse leading to overdose recently identified , in infants , '' said Linda A. Suydam , president of the trade association .
Next week , a committee of outside experts will consider the safety of these medicines .
